SENSIPHI
LIVE

Serial Number

79146712

Owner

QIAGEN GMBH

Attorney

Daniel M. Gurfinkel

Filing Date

Jan 13, 2014

Add to watchlist:

No watchlists yet
View on USPTO

SENSIPHI Trademark

Serial Number: 79146712 • Registration: 4714429

SENSIPHI is a trademark filed by QIAGEN GMBH on January 13, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

QIAGEN GMBH (212 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

January 13, 2014

Registration Date

April 7, 2015

Published for Opposition

January 20, 2015

Goods & Services

Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, namely, diagnostic reagents, enzymes and diagnostic reagents in the nature of buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; kits containing preparations for medical and veterinary diagnostic purposes, primarily consisting of diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid amplification

Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical chemical reagents, enzymes and chemical solutions in the nature of buffer solutions for scientific and/or medical research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular chemical reagents, enzymes and chemical solutions in the nature of buffer solutions for nucleic acid amplification; kits comprising chemicals for laboratory or research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material, in particular comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid amplification

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jun 30, 2025 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jun 30, 2025 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 30, 2025 APRE
TEAS SECTION 71 & 15 RECEIVED
Mar 18, 2025 ES75
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Apr 7, 2024 REM4
INTERNATIONAL REGISTRATION RENEWED
Jan 4, 2024 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jun 16, 2021 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jun 16, 2021 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 16, 2021 APRE
TEAS SECTION 71 & 15 RECEIVED
Mar 18, 2021 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 7, 2020 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 18, 2018 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 4, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 14, 2015 FICS
FINAL DISPOSITION PROCESSED
Aug 14, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 7, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 7, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 20, 2015 NPUB
PUBLISHED FOR OPPOSITION
Jan 20, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Jan 15, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 31, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 31, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 31, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 13, 2014 PREV
ASSIGNED TO LIE
Dec 13, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 25, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 24, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 24, 2014 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 23, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 23, 2014 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 22, 2014 NREP
REFUSAL PROCESSED BY IB
Jun 6, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 22, 2014 RFCS
REFUSAL PROCESSED BY MPU
May 22, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 21, 2014 RFCR
NON-FINAL ACTION WRITTEN
May 20, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
May 20, 2014 MAFR
ASSIGNED TO EXAMINER
May 16, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 16, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 15, 2014 REPR